Winton Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$710K Buy
+1,353
New +$710K 0.04% 513
2025
Q1
Sell
-313
Closed -$223K 775
2024
Q4
$223K Sell
313
-755
-71% -$538K 0.01% 552
2024
Q3
$1.12M Buy
+1,068
New +$1.12M 0.08% 228
2024
Q2
Sell
-4,664
Closed -$4.49M 708
2024
Q1
$4.49M Sell
4,664
-216
-4% -$208K 0.32% 57
2023
Q4
$4.29M Sell
4,880
-1,040
-18% -$913K 0.31% 48
2023
Q3
$4.87M Sell
5,920
-1,431
-19% -$1.18M 0.4% 37
2023
Q2
$5.28M Buy
7,351
+2,766
+60% +$1.99M 0.44% 43
2023
Q1
$3.77M Sell
4,585
-835
-15% -$686K 0.23% 73
2022
Q4
$3.91M Buy
5,420
+2,143
+65% +$1.55M 0.26% 59
2022
Q3
$2.26M Sell
3,277
-6,249
-66% -$4.3M 0.15% 172
2022
Q2
$5.63M Buy
9,526
+2,822
+42% +$1.67M 0.3% 55
2022
Q1
$4.68M Buy
6,704
+3,251
+94% +$2.27M 0.25% 75
2021
Q4
$2.18M Buy
3,453
+431
+14% +$272K 0.13% 200
2021
Q3
$1.83M Buy
3,022
+316
+12% +$191K 0.1% 224
2021
Q2
$1.51M Sell
2,706
-962
-26% -$537K 0.08% 304
2021
Q1
$1.74M Sell
3,668
-365
-9% -$173K 0.1% 196
2020
Q4
$1.95M Sell
4,033
-7,151
-64% -$3.45M 0.14% 114
2020
Q3
$6.26M Sell
11,184
-6,171
-36% -$3.45M 0.2% 72
2020
Q2
$10.8M Sell
17,355
-1,282
-7% -$799K 0.28% 33
2020
Q1
$9.1M Buy
18,637
+6,318
+51% +$3.08M 0.24% 78
2019
Q4
$4.63M Sell
12,319
-59,977
-83% -$22.5M 0.06% 501
2019
Q3
$20.1M Buy
72,296
+44,930
+164% +$12.5M 0.24% 137
2019
Q2
$8.57M Sell
27,366
-15,423
-36% -$4.83M 0.17% 185
2019
Q1
$17.6M Buy
42,789
+12,946
+43% +$5.32M 0.35% 103
2018
Q4
$11.1M Buy
29,843
+15,802
+113% +$5.9M 0.24% 173
2018
Q3
$5.67M Buy
+14,041
New +$5.67M 0.12% 267
2017
Q4
Sell
-11,543
Closed -$5.16M 701
2017
Q3
$5.16M Buy
11,543
+10,092
+696% +$4.51M 0.16% 152
2017
Q2
$713K Buy
+1,451
New +$713K 0.02% 445
2014
Q3
Sell
-10,424
Closed -$2.94M 679
2014
Q2
$2.94M Buy
+10,424
New +$2.94M 0.02% 413